Aldeyra Therapeutics
ALDX
ALDX
108 hedge funds and large institutions have $353M invested in Aldeyra Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 96 → 108 (+12)
2.35% more ownership
Funds ownership: 58.37% → 60.72% (+2.3%)
4% less call options, than puts
Call options by funds: $5.23M | Put options by funds: $5.45M
Holders
108
Holding in Top 10
2
Calls
$5.23M
Puts
$5.45M
Top Buyers
| 1 | +$8.59M | |
| 2 | +$8.46M | |
| 3 | +$6.26M | |
| 4 |
Millennium Management
New York
|
+$2.66M |
| 5 |
Goldman Sachs
New York
|
+$2.62M |
Top Sellers
| 1 | -$6.12M | |
| 2 | -$5.18M | |
| 3 | -$4.72M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.44M |
| 5 |
Two Sigma Investments
New York
|
-$2.29M |